cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Rapt Therapeutics Inc
7 own
5 watching
Current Price
$27.45
$-0.51
(-1.82%)
logo-rapt
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
820.38M
52-Week High
52-Week High
32.45
52-Week Low
52-Week Low
9.855
Average Volume
Average Volume
0.7M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization820.38M
icon52-Week High32.45
icon52-Week Low9.855
iconAverage Volume0.7M
iconDividend Yield--
iconP/E Ratio--
What does the Rapt Therapeutics Inc do?
RAPT Therapeutics, Inc.is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.
Read More
How much money does Rapt Therapeutics Inc make?
News & Events about Rapt Therapeutics Inc.
Globe Newswire
24days ago
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in ...
Globe Newswire
1month ago
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc.(Nasdaq: RAPT) (RAPT or the Company), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant ...
Globe Newswire
2 months ago
SOUTH SAN FRANCISCO, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc.(Nasdaq: RAPT) (RAPT or the Company), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant ...
Globe Newswire
2 months ago
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in ...
Market News Video
2 months ago
In trading on Friday, shares of RAPT Therapeutics Inc (RAPT) crossed below their 200 day moving average of 20.72, changing hands as low as 20.04 per share. RAPT Therapeutics Inc shares are currently trading down about 3.1% on the day...
Frequently Asked Questions
Frequently Asked Questions
What is Rapt Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Rapt Therapeutics Inc shares?
plus_minus_icon
How can I buy Rapt Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Rapt Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Rapt Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Rapt Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Rapt Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Rapt Therapeutics Inc?
plus_minus_icon
What percentage is Rapt Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Rapt Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$27.45
$-0.51
(-1.82%)
logo-rapt
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00